Literature DB >> 10673807

An instrument to measure symptom experience. Symptom occurrence and symptom distress.

V A Rhodes1, R W McDaniel, S S Homan, M Johnson, R Madsen.   

Abstract

This article describes the development of an instrument that measures symptom experience (symptom occurrence and symptom distress). The Adapted Symptom Distress Scale-2 (ASDS-2), adapted from the McCorkle and Young Distress Scale, is a 31-item, 5-point, self-report paper-and-pencil instrument that measures patients' perception of the occurrence and distress of 14 symptoms: nausea, vomiting, pain, eating, sleep, fatigue, bowel elimination, breathing, coughing, concentration, lacrimation, changes in body temperature, appearance, and restlessness. Use of the instrument yields a total score for symptom experience, scores for symptom occurrence, scores for symptom distress, and subscale scores for six symptom categories: gastrointestinal, fatigue/restlessness, concentration, pain/discomfort, respiratory, and appearance. Reliability and validity were determined with well adults (n = 97), medical-surgical patients (n = 82), and oncology patients (n = 175). Findings revealed a Cronbach's alpha of 0.91 for symptom experience, 0.90 for symptom occurrence, and 0.76 for symptom distress. Cronbach's alpha for the subscales ranged from 0.38 for appearance symptoms to 0.83 for gastrointestinal symptoms. Inclusion of symptoms reported by patients with cancer strengthened content validity. A contrasted groups approach was used to demonstrate construct validity.

Entities:  

Mesh:

Year:  2000        PMID: 10673807     DOI: 10.1097/00002820-200002000-00008

Source DB:  PubMed          Journal:  Cancer Nurs        ISSN: 0162-220X            Impact factor:   2.592


  6 in total

Review 1.  The psychometric properties of cancer multisymptom assessment instruments: a clinical review.

Authors:  Aynur Aktas; Declan Walsh; Jordanka Kirkova
Journal:  Support Care Cancer       Date:  2015-04-19       Impact factor: 3.603

2.  The effect of abdominal support on functional outcomes in patients following major abdominal surgery: a randomized controlled trial.

Authors:  Oren Cheifetz; S Deborah Lucy; Tom J Overend; Jean Crowe
Journal:  Physiother Can       Date:  2010-07-23       Impact factor: 1.037

3.  Network Analysis of the Multidimensional Symptom Experience of Oncology.

Authors:  Nikolaos Papachristou; Payam Barnaghi; Bruce Cooper; Kord M Kober; Roma Maguire; Steven M Paul; Marilyn Hammer; Fay Wright; Jo Armes; Eileen P Furlong; Lisa McCann; Yvette P Conley; Elisabeth Patiraki; Stylianos Katsaragakis; Jon D Levine; Christine Miaskowski
Journal:  Sci Rep       Date:  2019-02-19       Impact factor: 4.379

4.  Evaluation of the Symptom Representation Questionnaire (SRQ) for assessing cancer-related symptoms.

Authors:  Heidi Scharf Donovan; Sandra Ward; Paula Sherwood; Ronald C Serlin
Journal:  J Pain Symptom Manage       Date:  2008-01-16       Impact factor: 3.612

5.  A longitudinal study of patients' symptoms before and during the first year after lung transplantation.

Authors:  Dorothy M Lanuza; Cheryl A Lefaiver; Roger Brown; Rebecca Muehrer; Margaret Murray; Maria Yelle; Sangeeta Bhorade
Journal:  Clin Transplant       Date:  2012-09-18       Impact factor: 2.863

6.  Virtual reality: a distraction intervention for chemotherapy.

Authors:  Susan M Schneider; Linda E Hood
Journal:  Oncol Nurs Forum       Date:  2007-01       Impact factor: 2.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.